Literature DB >> 6189940

Relationship between expression of herpes simplex virus glycoproteins and susceptibility of target cells to human natural killer activity.

G A Bishop, J C Glorioso, S A Schwartz.   

Abstract

Cells normally insensitive to human natural killer (NK) activity were rendered susceptible by infection with HSV-1. The cytotoxic effector cell was a nonadherent, non-T, non-B lymphocyte. Antibody plus complement treatment, using a monoclonal antibody that recognizes an antigen present on NK cells, removed much of the cytotoxic activity, and a density gradient fraction enriched for NK cells yielded cells of increased virus-specific cytotoxicity. It was concluded that the effector cell active against infected targets possessed characteristics of an NK cell. Blockage of viral protein synthesis during infection inhibited development of increased susceptibility of infected targets to NK activity. When targets were infected with a mutant virus unable to produce viral glycoprotein C (gC), NK activity against these targets was reduced approximately 30% compared with activity against targets infected with wild-type virus. Similarly, activity against targets infected in the presence of 2-deoxyglucose (2dG), which prevents cell surface expression of viral glycoprotein B (gB), was also reduced approximately 30%. An approximately 60% reduction in activity was seen against targets infected with mutant virus in the presence of 2dG; these targets express gD, but neither gB nor gC. When cells expressing various combinations of HSV-1 glycoproteins were used as both labeled targets and cold target competitors, it was found that the susceptibility of a particular target to NK activity was paralleled by its ability to act as a cold target competitor. This indicates that targets with decreased sensitivity to NK cells were less able to bind NK effectors. Further, the amount of interferon produced in co-cultures of NK effectors and infected target cells did not directly correlate with the amount of NK activity generated, and interferon pretreatment of effectors did not decrease virus-specific cytotoxicity. The present results suggest that HSV-1 glycoproteins expressed at the surface of infected targets may act as recognition structures for NK cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6189940      PMCID: PMC2187020          DOI: 10.1084/jem.157.5.1544

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  47 in total

1.  In vitro production of immune interferon by spleen cells of mice immunized with herpes simplex virus.

Authors:  H Kirchner; R Zawatzky; H M Hirt
Journal:  Cell Immunol       Date:  1978-09-15       Impact factor: 4.868

2.  Membrane proteins specified by herpes simplex viruses. I. Identification of four glycoprotein precursors and their products in type 1-infected cells.

Authors:  P G Spear
Journal:  J Virol       Date:  1976-03       Impact factor: 5.103

3.  Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma.

Authors:  G Henle; W Henle
Journal:  Int J Cancer       Date:  1976-01-15       Impact factor: 7.396

4.  Aquanititave semimicro, semiautomated colorimetric assay for interferon.

Authors:  E C Borden; P H Leonhardt
Journal:  J Lab Clin Med       Date:  1977-05

5.  Inhibition of the growth of lymphoid tumours in syngeneic athymic (nude) mice.

Authors:  N L Warner; M F Woodruff; R C Burton
Journal:  Int J Cancer       Date:  1977-07-15       Impact factor: 7.396

6.  Separation of mouse spleen cells by passage through columns of sephadex G-10.

Authors:  I A Ly; R I Mishell
Journal:  J Immunol Methods       Date:  1974-08       Impact factor: 2.303

7.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

8.  Cell-mediated cytotoxicity against virus-infected target cells in humans. II. Interferon induction and activation of natural killer cells.

Authors:  D Santoli; G Trinchieri; H Koprowski
Journal:  J Immunol       Date:  1978-08       Impact factor: 5.422

Review 9.  Do natural killer cells engage in regulated reactions against self to ensure homeostasis?

Authors:  G Cudkowicz; P S Hochman
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

10.  Cell-mediated cytotoxicity against virus-infected target cells in humans. I. Characterization of the effector lymphocyte.

Authors:  D Santoli; G Trinchieri; F S Lief
Journal:  J Immunol       Date:  1978-08       Impact factor: 5.422

View more
  23 in total

1.  Antigenic variation (mar mutations) in herpes simplex virus glycoprotein B can induce temperature-dependent alterations in gB processing and virus production.

Authors:  S D Marlin; S L Highlander; T C Holland; M Levine; J C Glorioso
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

2.  In vivo expression of perforin by natural killer cells during a viral infection. Studies on uveitis produced by herpes simplex virus type I.

Authors:  L H Young; C S Foster; J D Young
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

3.  Epitopes of herpes simplex virus type 1 glycoprotein gC are clustered in two distinct antigenic sites.

Authors:  S D Marlin; T C Holland; M Levine; J C Glorioso
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

4.  Lysis of varicella zoster virus infected cells by lymphocytes from normal humans and immunosuppressed pediatric leukaemic patients.

Authors:  R A Bowden; M J Levin; R H Giller; D G Tubergen; A R Hayward
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

5.  The Fc Domain of Immunoglobulin Is Sufficient to Bridge NK Cells with Virally Infected Cells.

Authors:  Hong-Sheng Dai; Nathaniel Griffin; Chelsea Bolyard; Hsiaoyin Charlene Mao; Jianying Zhang; Timothy P Cripe; Tadahiro Suenaga; Hisashi Arase; Ichiro Nakano; E A Chiocca; Balveen Kaur; Jianhua Yu; Michael A Caligiuri
Journal:  Immunity       Date:  2017-07-18       Impact factor: 31.745

6.  Expression of the Pseudorabies Virus gB Glycoprotein Triggers NK Cell Cytotoxicity and Increases Binding of the Activating NK Cell Receptor PILRβ.

Authors:  Steffi De Pelsmaeker; Evelien Dierick; Barbara Klupp; Thomas C Mettenleiter; Claudia Cantoni; Massimo Vitale; Herman W Favoreel
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

7.  Heterogeneity amongst natural killer cells revealed by limiting dilution culture; selectivity against virus-infected and tumour cell targets.

Authors:  P D Mason; J G Sissons; L K Borysiewicz
Journal:  Immunology       Date:  1993-12       Impact factor: 7.397

8.  Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection.

Authors:  E M Cantin; R Eberle; J L Baldick; B Moss; D E Willey; A L Notkins; H Openshaw
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

9.  Specificity of human natural killer cells in limiting dilution culture for determinants of herpes simplex virus type 1 glycoproteins.

Authors:  G A Bishop; G Kümel; S A Schwartz; J C Glorioso
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

10.  Effects of phosphorylation of herpes simplex virus 1 envelope glycoprotein B by Us3 kinase in vivo and in vitro.

Authors:  Takahiko Imai; Ken Sagou; Jun Arii; Yasushi Kawaguchi
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.